Evaluating a Therapeutic Agent That May Inhibit a Protein Associated with Lymphoma
This study evaluates a new therapeutic agent designed to inhibit the survivin protein in canine lymphoma.
Displaying 533 - 539 of 539 Results
Understanding How Mammary Cancer Develops
This study investigates the role of citrullination in canine mammary cancer and how interfering with this process might lead to more effective anticancer treatments.
Identifying Genetic Mutations That Cause Extrahepatic Portosystemic Shunts in Dogs
This study will determine the genetic and functional differences of eight genes that are strongly associated with congenital extrahepatic portosystemic shunts in several small dog breeds.
Identifying How Ophthalmic Steroids Affect Diabetes Regulation in Dogs
This study investigates the effects of topical ophthalmic prednisolone (steroid) and diclofenac (nonsteroidal anti-inflammatory drug) on diabetes mellitus regulation in client-owned dogs.
Assessing Immune Stimulation as a Potential Therapy for Osteosarcoma
This study will characterize the expression of toll-like receptors, which activate the immune system, in canine osteosarcoma cells to better determine the biological consequences associated with activating these receptors.
Testing Strategies to Treat Drug-Resistant Hemangiosarcomas
Investigators are assessing the potential for a specific tumor-cell population in canine hemangiosarcoma to sequester drugs within their lysosomes as a novel mechanism of drug resistance.
Assessing the NDY1 Protein as a Potential Treatment for Mast Cell Cancer
The goal of this study is to determine new strategies for treating canine mast cell tumors based on the targeting of a DNA-packaging protein called NDY1.